Graves Disease
📧 Sign up to get email alerts when something new happens for Graves Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-08-26FDA Approved: METHIMAZOLE — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for methimazole (generic) submitted by NorthStar RX LLC.
-
FDA approval · 2025-07-21FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA supplemental approval for Methimazole involving Chartwell RX, LLC under an ANDA, confirming regulatory status for a generic methimazole …
-
FDA approval · 2025-02-05FDA Approved: METHIMAZOLE — Original Application (Viona Pharmaceuticals Inc.)
FDA approves an original ANDA for methimazole from Viona Pharmaceuticals Inc., for the treatment of hyperthyroidism (including Graves' disea…
-
FDA approval · 2024-06-26FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Propylthiouracil from Macleods Pharmaceuticals Limited (ANDA208867).
-
FDA approval · 2023-09-25FDA Approved: METHIMAZOLE — Original Application (Bionpharma Inc.)
The FDA approved an original application for a generic Methimazole from Bionpharma Inc., adding a generic version of the antithyroid medicat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-10-20FDA Approved: METHIMAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approves a supplemental application from Rising Pharma Holdings, Inc. for a generic methimazole product, expanding access to the labeled…
-
FDA approval · 2021-10-20FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application from Strides Pharma Science Limited for methimazole, a generic antithyroid medication. The appro…
-
FDA approval · 2021-03-18FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved a supplemental application for Propylthiouracil from Quagen Pharmaceuticals LLC under the ANDA process.
-
FDA approval · 2019-01-23FDA Approved: METHIMAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for methimazole from Rising Pharma Holdings, expanding the availability of this generic treatmen…
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
FDA approves a supplemental application for Strides Pharma Science Limited's methimazole, updating the already approved product under an AND…
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (NORTHSTAR RX LLC)
The FDA approved a supplemental application for methimazole submitted by NorthStar RX LLC.
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Methimazole submitted by Chartwell RX, LLC (ANDA).
-
FDA approval · 2018-09-19FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Endo USA, Inc.)
FDA approves a supplemental application for Propylthiouracil from Endo USA, Inc.
-
FDA approval · 2016-01-15FDA Approved: METHIMAZOLE — Supplemental Application (NORTHSTAR RX LLC)
The FDA approved a supplemental application for methimazole filed by Northstar RX LLC.
-
FDA approval · 2016-01-15FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for methimazole from Chartwell RX, LLC, marking a supplemental approval for this generic antithyroid…
-
FDA approval · 2016-01-15FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for methimazole submitted by Strides Pharma Science Limited.
-
FDA approval · 2016-01-15FDA Approved: METHIMAZOLE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' supplemental application for Methimazole (generic antithyroid drug), resulting in labeling changes.
-
FDA approval · 2013-12-19FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental NDA for Propylthiouracil submitted by Endo USA, Inc., updating the labeling to reflect the approved changes.…
-
FDA approval · 2012-07-11FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for methimazole filed by Strides Pharma Science Limited.
-
FDA approval · 2012-03-07FDA Approved: METHIMAZOLE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s original application for methimazole, a generic antithyroid medication used to treat hyperthyroi…
-
FDA approval · 2011-10-13FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propylthiouracil from Actavis Pharma, Inc., under the ANDA pathway.
-
FDA approval · 2011-08-22FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)
The FDA approved a supplemental ANDA for propylthiouracil from Quagen Pharmaceuticals LLC, authorizing the marketing of an additional generi…
-
FDA approval · 2011-08-22FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for methimazole submitted by Chartwell RX, LLC. This action updates the product's labeling/manufactu…
-
FDA approval · 2011-03-28FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for methimazole submitted by Chartwell RX, LLC.
-
FDA approval · 2011-01-21FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propylthiouracil by Actavis Pharma, Inc., indicating a labeling update under the already app…